Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Merilin Feldman"'
Autor:
Erica L. Mayer, Sara Tolaney, Adam M. Brufsky, William Gradishar, Komal Jhaveri, Miguel Martín, Luca Moscetti, Gregory Vidal, Patricia Cortazar, Merilin Feldman, Bann-mo Day, Hope Rugo
Publikováno v:
Cancer Research. 83:OT2-01
BACKGROUND Endocrine therapy (ET) modulates estrogen synthesis and/or estrogen receptor (ER) activity and is the mainstay of ER+ breast cancer (BC) treatment. ET + a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) is the standard of care in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f046539149f287928b3e8af622b87b4
https://doi.org/10.1158/1538-7445.sabcs22-ot2-01-07
https://doi.org/10.1158/1538-7445.sabcs22-ot2-01-07
